Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 6, 2010 - Issue 5
Submit an article Journal homepage
130
Views
11
CrossRef citations to date
0
Altmetric
Clinical Trial Report

RAPID and FAST4WARD trials: certolizumab pegol for rheumatoid arthritis

Sofia Ramiro Department of Medicine, Division of Rheumatology, Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, The Netherlands; School for Public Health and Primary Care (CAPHRI), Maastricht, The Netherlands; Department of Rheumatology, Hospital Garcia de Orta, Portugal; Department of Medicine, Division of Rheumatology, Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, The Netherlands; School for Public Health and Primary Care (CAPHRI), Maastricht, The Netherlands; Department of Rheumatology, Hospital Garcia de Orta, Portugal
,
Astrid M van Tubergen Department of Medicine, Division of Rheumatology, Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, The Netherlands; School for Public Health and Primary Care (CAPHRI), Maastricht, The Netherlands; Department of Medicine, Division of Rheumatology, Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, The Netherlands; School for Public Health and Primary Care (CAPHRI), Maastricht, The Netherlands
&
Robert BM Landewé Department of Medicine, Division of Rheumatology, Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, The Netherlands; School for Public Health and Primary Care (CAPHRI), Maastricht, The Netherlands;[email protected]
Pages 713-720 | Published online: 10 Jan 2014

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Yoshiya Tanaka, Kazuhiko Yamamoto, Tsutomu Takeuchi, Hisashi Yamanaka, Naoki Ishiguro, Katsumi Eguchi, Akira Watanabe, Hideki Origasa, Toshiharu Shoji, Nobuyuki Miyasaka & Takao Koike. (2014) Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: 52-week results from an open-label extension of the J-RAPID study. Modern Rheumatology 24:5, pages 734-743.
Read now
Kazuhiko Yamamoto, Tsutomu Takeuchi, Hisashi Yamanaka, Naoki Ishiguro, Yoshiya Tanaka, Katsumi Eguchi, Akira Watanabe, Hideki Origasa, Koichi Iwai, Yoshiharu Sakamaki, Désirée van der Heijde, Nobuyuki Miyasaka & Takao Koike. (2014) Efficacy and safety of certolizumab pegol without methotrexate co-administration in Japanese patients with active rheumatoid arthritis: The HIKARI randomized, placebo-controlled trial. Modern Rheumatology 24:4, pages 552-560.
Read now
Maria Sole Chimenti, Rosita Saraceno, Andrea Chiricozzi, Alessandro Giunta, Sergio Chimenti & Roberto Perricone. (2013) Profile of certolizumab and its potential in the treatment of psoriatic arthritis. Drug Design, Development and Therapy 7, pages 339-348.
Read now

Articles from other publishers (8)

Charlotte Rawlings & Ernest Choy. (2014) The future of biological agents in the treatment of rheumatoid arthritis. International Journal of Clinical Rheumatology 9:5, pages 475-486.
Crossref
Isabelle Cleynen & Séverine Vermeire. (2012) Paradoxical inflammation induced by anti-TNF agents in patients with IBD. Nature Reviews Gastroenterology & Hepatology 9:9, pages 496-503.
Crossref
Lara Valor & Inmaculada de la Torre Ortega. (2012) Should We Use Poor Prognosis Factors to Start Early Treatment in Patients With Rheumatoid Arthritis?. Reumatología Clínica (English Edition) 8:4, pages 163-167.
Crossref
Lara Valor & Inmaculada de la Torre Ortega. (2012) ¿Debemos usar los factores de mal pronóstico para iniciar precozmente un tratamiento biológico en los pacientes con artritis reumatoide?. Reumatología Clínica 8:4, pages 163-167.
Crossref
Jeffrey R. Curtis, Kristel Luijtens & Arthur Kavanaugh. (2012) Predicting future response to certolizumab pegol in rheumatoid arthritis patients: Features at 12 weeks associated with low disease activity at 1 year. Arthritis Care & Research 64:5, pages 658-667.
Crossref
Florian David, Miriam Steinwand, Michael Hust, Kathrin Bohle, Anton Ross, Stefan Dübel & Ezequiel Franco-Lara. (2011) Antibody production in Bacillus megaterium: Strategies and physiological implications of scaling from microtiter plates to industrial bioreactors. Biotechnology Journal 6:12, pages 1516-1531.
Crossref
G. Ducarme, P. Amate, M. Seirafi, P.-F. Ceccaldi, Y. Bouhnik & D. Luton. (2011) Médicaments anti-TNFα (tumor necrosis factor α) en gynécologie et en obstétrique. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 40:6, pages 492-497.
Crossref
Svenja Lüders, Florian David, Miriam Steinwand, Eva Jordan, Michael Hust, Stefan Dübel & Ezequiel Franco-Lara. (2011) Influence of the hydromechanical stress and temperature on growth and antibody fragment production with Bacillus megaterium. Applied Microbiology and Biotechnology 91:1, pages 81-90.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.